As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Aethlon Medical Inc. The largest reported stake is Jane Street Group, LLC's, at 5%. 10 filings are on record since August 14, 2025 (Schedule 13G, October 13, 2026).
Sell to companies like Aethlon Medical Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Jane Street Group, LLC · Sole voting: 0 · Shared voting: 35,819 · Sole dispositive: 0 · Shared dispositive: 35,819 · SCHEDULE 13G, 2026-10-13
- · Reporting person: Mitchell P. Kopin · Sole voting: 0 · Shared voting: 55,556 · Sole dispositive: 0 · Shared dispositive: 55,556 · SCHEDULE 13G/A, 2026-08-13
- · Holder: Armistice Capital, LLC · Percent: 4.99% · SCHEDULE 13G/A
- · Holder: Armistice Capital, LLC · Percent: 9.99% · SCHEDULE 13G
- · Holder: Alumni Capital LP · Percent: 4.05% · SCHEDULE 13G/A
Aethlon Medical Inc has 10 Schedule 13D or 13G filings on record since 2025-08-14. 1 holder's latest filing reports 5% or more of common stock, $0.001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Jane Street Group, LLC | 5% | 35,819 | SCHEDULE 13G, 2026-10-13 | 2026-10-06 |
| Armistice Capital, LLC | 4.99% | 82,410 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Alumni Capital LP | 4.05% | 55,555 | SCHEDULE 13G/A, 2026-02-17 | 2025-10-31 |
| 2.3% | 55,556 | SCHEDULE 13G/A, 2026-08-13 | 2026-06-30 | |
| Ikarian Capital, LLC | 2% | 15,366 | SCHEDULE 13G/A, 2025-11-14 | 2025-09-30 |
Holding shares or following this stake? See who's behind Aethlon Medical Inc and the warning signs.
Free to see. No signup.
Keep reading
More on Aethlon Medical Inc and the records around it.
Aethlon Medical Inc elsewhere on the record
- Form D filing Dec 2025
- Who owns it
Companies that share a holder
- Alumni Capital LP also filed stake reports on 12 other companies: reAlpha Tech Corp. (Nov 2026), Sports Entertainment Gaming Global Corp (Nov 2026), NEXALIN TECHNOLOGY, INC. (Aug 2026)
- Ikarian Capital, LLC also filed stake reports on 22 other companies: Quoin Pharmaceuticals Ltd. (Oct 2026), Connect Biopharma Holdings Limited (Aug 2026), Galera Therapeutics, Inc. (Aug 2026)
- Mitchell P. Kopin also filed stake reports on 55 other companies: SCWorx Corp. (Sep 2026), NFT Limited (Aug 2026), Silexion Therapeutics Corp (Aug 2026)
Watch Aethlon Medical Inc
Get an email when Aethlon Medical Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Aethlon Medical Inc?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Aethlon Medical Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Aethlon Medical Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 0 | 35,819 | 0 | 35,819 | SCHEDULE 13G, 2026-10-13 |
| Jane Street Capital, LLC | 0 | 6,845 | 0 | 6,845 | SCHEDULE 13G, 2026-10-13 |
| Jane Street Global Trading, LLC | 0 | 28,974 | 0 | 28,974 | SCHEDULE 13G, 2026-10-13 |
| Mitchell P. Kopin | 0 | 55,556 | 0 | 55,556 | SCHEDULE 13G/A, 2026-08-13 |
| Daniel B. Asher | 0 | 55,556 | 0 | 55,556 | SCHEDULE 13G/A, 2026-08-13 |
| Intracoastal Capital LLC | 0 | 55,556 | 0 | 55,556 | SCHEDULE 13G/A, 2026-08-13 |
The latest filing identifies Aethlon Medical Inc by CUSIP 00808Y703 and gives its principal executive office as 11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA 92121 (SCHEDULE 13G, 2026-10-13).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | Armistice Capital, LLC | 7.16% | SCHEDULE 13G/A |
| 2025-09-10 | Mitchell P. Kopin | 7.7% | SCHEDULE 13G |
| 2025-09-22 | Alumni Capital LP | 9.58% | SCHEDULE 13G |
| 2025-11-14 | Armistice Capital, LLC | 4.99% | SCHEDULE 13G/A |
| 2025-11-14 | Ikarian Capital, LLC | 2% | SCHEDULE 13G/A |
| 2026-02-17 | Armistice Capital, LLC | 9.99% | SCHEDULE 13G |
| 2026-02-17 | Alumni Capital LP | 4.05% | SCHEDULE 13G/A |
| 2026-05-15 | Armistice Capital, LLC | 4.99% | SCHEDULE 13G/A |
| 2026-08-13 | Mitchell P. Kopin | 2.3% | SCHEDULE 13G/A |
| 2026-10-13 | Jane Street Group, LLC | 5% | SCHEDULE 13G |
Questions about who owns Aethlon Medical Inc
Who owns Aethlon Medical Inc?
On this page, one holder's latest ownership filing reports 5% or more of Aethlon Medical Inc: Jane Street Group, LLC (5%, Schedule 13G, filed 2026-10-13).
When did Jane Street Group, LLC buy into Aethlon Medical Inc?
The filings give report dates, not purchase dates. The earliest filing from Jane Street Group, LLC on this page is the Schedule 13G, filed 2026-10-13, reporting 5%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Aethlon Medical Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| December 23, 2025 | Form D, private offering | $2.15M sold | Form D page | Source |
Tools for this story
Each opens in a new tab, filled in for Aethlon Medical Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.